Results 231 to 240 of about 104,334 (371)

The Relationship Between The Multimeric Structure Of F VIII-VWF And The Facilitation Of Platelet Adhesion To Human Subendothelium (Von Willebrand Factor Activity VWF-A) [PDF]

, 1981
Jan J. Sixma, Kjell S. Sakaríassen, P. A. Bolhuis   +2 more
openalex   +1 more source

Comprehensive bioinformatics analysis of the role of VWF in the tumor microenvironment of malignant mesothelioma

, 2023
J. Weng, Jing Chen
openalex   +1 more source

Assessing primary hemostasis in cirrhosis: not only platelet count. [PDF]

Res Pract Thromb Haemost
Ferdinande K, Zanetto A.
europepmc   +1 more source

Treatment of von Willebrand disease with FVIII/VWF concentrates.

, 2011
Giancarlo Castaman
openalex   +2 more sources

ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854Gln, and the missense mutation Cys2362Phe [PDF]

, 2002
Giancarlo Castaman, Jeroen Eikenboom
openalex   +1 more source

Effect of lower VWF and FXI levels on levonorgestrel IUS and endometrial ablation treatment success in heavy menstrual bleeding: An exploratory study

, 2021
M. Brink, S. Wiewel‐Verschueren, Pleun Beelen, Joep W. van Borselen, Marlies Y. Bongers, Michaël V. Lukens, Janny H. Dekker, Karina Meijer   +7 more
openalex   +2 more sources

Regulation of VWF expression, and secretion in health and disease

Current opinion in hematology, 2016
Yaozu Xiang, J. Hwa
semanticscholar   +1 more source

Cardioprotective effects of prolyl hydroxylase inhibitors during reperfusion in myocardial infarction: A study using cardiosphere‐derived cells

Experimental Physiology, EarlyView.
Abstract Cardiosphere‐derived cells (CDCs) are a promising in vitro model for studying myocardial ischaemia–reperfusion (I–R) injury and testing potential therapeutic interventions. This study investigated the suitability of CDCs as a model for myocardial infarction (MI) and the effects of prolyl hydroxylase inhibitor (PHI) administration during ...
Luca Salhöfer, Ulrike B. Hendgen‐Cotta, Joachim Fandrey, Timm Schreiber, Tristan Leu   +4 more
wiley   +1 more source

Recombinant von Willebrand factor for von Willebrand disease: mechanism of action and clinical application. [PDF]

Ther Adv Hematol
Hua Z, Miao W, Zhang P, Yang R.
europepmc   +1 more source

Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom [PDF]

, 2016
Arita, Asplin, Bailey, Bailey, Beltowski, Blakesley, Borer, Bremer, Brooks, Carter, Cywinska, Dallmeier, Efstathiou, El-Mesallamy, Fesus, Finding, Firshman, Frank, Frank, Giles, Giordano, Greiner, Heinrichs, Henneke, Hinckley, Holbrook, Hotta, Huang, Ingelsson, Johnson, Kearns, Kim, Kullmann, Laat, Lam, Lavoie-Lamoureux, Lim, Luszczynski, Lygren, Macieira, Maleki, Mattu, Morgan, Orth, Ouchi, Pischon, Pleasant, Pollock, Popot, Pratt, Ragab, Reimers, Robin, Rosen, Ruan, Ruan, Ryu, Salazar-Ortiz, Salonen, Sandhu, Schultz, Smith, Stephenson, Takiguchi, Torres, Treiber, Treiber, Treiber, Treiber, Troncoso, Trujillo, Wannamethee, Wray, Wyse, Yang   +74 more
core   +2 more sources